1. Home
  2. NVTS vs TRML Comparison

NVTS vs TRML Comparison

Compare NVTS & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVTS
  • TRML
  • Stock Information
  • Founded
  • NVTS 2014
  • TRML 2021
  • Country
  • NVTS United States
  • TRML United States
  • Employees
  • NVTS N/A
  • TRML N/A
  • Industry
  • NVTS Semiconductors
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • NVTS Technology
  • TRML Health Care
  • Exchange
  • NVTS Nasdaq
  • TRML Nasdaq
  • Market Cap
  • NVTS 1.3B
  • TRML 1.2B
  • IPO Year
  • NVTS N/A
  • TRML N/A
  • Fundamental
  • Price
  • NVTS $7.85
  • TRML $47.90
  • Analyst Decision
  • NVTS Buy
  • TRML Hold
  • Analyst Count
  • NVTS 7
  • TRML 12
  • Target Price
  • NVTS $4.93
  • TRML $47.04
  • AVG Volume (30 Days)
  • NVTS 27.9M
  • TRML 957.5K
  • Earning Date
  • NVTS 11-03-2025
  • TRML 11-06-2025
  • Dividend Yield
  • NVTS N/A
  • TRML N/A
  • EPS Growth
  • NVTS N/A
  • TRML N/A
  • EPS
  • NVTS N/A
  • TRML N/A
  • Revenue
  • NVTS $68,167,000.00
  • TRML N/A
  • Revenue This Year
  • NVTS N/A
  • TRML N/A
  • Revenue Next Year
  • NVTS $8.28
  • TRML N/A
  • P/E Ratio
  • NVTS N/A
  • TRML N/A
  • Revenue Growth
  • NVTS N/A
  • TRML N/A
  • 52 Week Low
  • NVTS $1.52
  • TRML $11.56
  • 52 Week High
  • NVTS $9.48
  • TRML $48.27
  • Technical
  • Relative Strength Index (RSI)
  • NVTS 61.60
  • TRML 91.37
  • Support Level
  • NVTS $7.50
  • TRML $47.83
  • Resistance Level
  • NVTS $8.49
  • TRML $47.94
  • Average True Range (ATR)
  • NVTS 0.60
  • TRML 0.11
  • MACD
  • NVTS 0.17
  • TRML -0.63
  • Stochastic Oscillator
  • NVTS 66.47
  • TRML 38.14

About NVTS Navitas Semiconductor Corporation

Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: